Dr. Bradley R. Corr
Claim this profileUniversity of Colorado Hospital
Studies Ovarian Cancer
Studies Cancer
20 reported clinical trials
33 drugs studied
Area of expertise
1Ovarian Cancer
Stage IV
Stage II
Stage III
2Cancer
Stage IV
BRCA1 negative
BRCA2 negative
Affiliated Hospitals
Clinical Trials Bradley R. Corr is currently running
Ipatasertib + Megestrol Acetate
for Endometrial Cancer
This trial is testing if combining two drugs, ipatasertib and megestrol acetate, is more effective than using megestrol acetate alone for treating women with endometrial cancer that has returned or spread. Ipatasertib blocks enzymes needed for cancer cell growth, while megestrol acetate reduces and blocks estrogen, which some cancer cells need to grow.
Recruiting1 award Phase 1 & 2
Megestrol + Metformin
for Endometrial Cancer Prevention
This phase II trial studies the effect of megestrol acetate alone or in combination with metformin in preventing the progression of uterine pre-cancer (endometrial intraepithelial neoplasia) to endometrial cancer. Megestrol acetate is a drug used to block estrogen and suppress the effects of estrogen and androgens. It is the current non-surgical treatment of endometrial intraepithelial neoplasia. Metformin is a drug that has been found to have anti-cancer properties. Giving metformin and megestrol acetate together may decrease the growth of endometrial intraepithelial neoplasia in the uterus better than megestrol alone.
Recruiting1 award Phase 214 criteria
More about Bradley R. Corr
Clinical Trial Related1 year of experience running clinical trials · Led 20 trials as a Principal Investigator · 12 Active Clinical TrialsTreatments Bradley R. Corr has experience with
- Paclitaxel
- Letrozole
- Megestrol Acetate
- Carboplatin
- Mirvetuximab Soravtansine
- BMS-986249
Breakdown of trials Bradley R. Corr has run
Ovarian Cancer
Cancer
Fallopian Tube Cancer
Ovarian Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bradley R. Corr specialize in?
Bradley R. Corr focuses on Ovarian Cancer and Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage II.
Is Bradley R. Corr currently recruiting for clinical trials?
Yes, Bradley R. Corr is currently recruiting for 12 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Bradley R. Corr has studied deeply?
Yes, Bradley R. Corr has studied treatments such as Paclitaxel, Letrozole, Megestrol Acetate.
What is the best way to schedule an appointment with Bradley R. Corr?
Apply for one of the trials that Bradley R. Corr is conducting.
What is the office address of Bradley R. Corr?
The office of Bradley R. Corr is located at: University of Colorado Hospital, Aurora, Colorado 80045 United States. This is the address for their practice at the University of Colorado Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.